Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-09

Clinical Trial Update: Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of extended-release oxymorphone taken with or without food on cognitive functioning in chronic pain patients; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone Extended Release (oxymorphone)

Snippet

Sponsor: MedVadis Research Corporation | Conditions: Chronic Pain | Phase 4 | Status: COMPLETED | Results posted: 2023-05-09